STOCK TITAN

KOSS 10-Q Filings

KOSS NASDAQ

Here are the 10-Q quarterly reports from Koss Corp (KOSS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow KOSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KOSS filings page.

Rhea-AI Summary

Koss Corporation reported net sales of $3,094,078 for the three months ended September 30, 2026, down 24.0% from $4,070,778 a year earlier. It recorded a net loss of $234,168, compared with net income of $243,729. Gross profit margin was 39.5%, compared with 40.0% in the prior-year quarter.

Operating activities used $524,275 of cash, compared with $762,617 provided a year earlier. Cash and cash equivalents were $2,014,772, and available-for-sale U.S. Treasury securities had a fair value of $16,707,708 at September 30, 2026. Koss attributed the sales decline primarily to a considerable Education-segment sale tied to a new product introduction in the prior-year quarter that did not recur. The company said higher freight rates and tariff uncertainty affected costs and sales volumes, and expected shipment costs to be consistent or increase in the coming quarter. Its $5,000,000 revolving secured credit facility had no outstanding borrowings at September 30, 2026; an amendment effective October 30, 2026 extended maturity to October 31, 2028.

Rhea-AI Summary

Koss Corporation reported modest sales growth but wider losses for the quarter ended March 31, 2026. Net sales for the quarter inched up to $2.8 million, with stronger U.S. demand and direct-to-consumer sales offset by sharply lower export revenue. For the nine months, sales reached $9.8 million, helped by education and distribution orders.

Gross margin fell to 35.5% from 39.0% as tariffs and earlier high freight costs pressured profitability, leading to a nine‑month net loss of $868,265. Koss reclassified about $17.0 million of U.S. Treasury securities to available-for-sale to support a diversification-by-acquisition strategy. The company ended the period with $1.9 million in cash, $17.0 million in liquid investments, no borrowings on a $5 million credit facility, and significant tax loss carryforwards.

Rhea-AI Summary

Koss Corporation reported a weaker quarter ended December 31, 2025. Net sales fell to $2.9 million from $3.6 million, mainly because prior-year European new product orders did not repeat, while domestic sales grew modestly and an education customer drove first-half growth.

Gross margin dropped to 29.0% from 39.5%, pressured by high tariffs on China-sourced inventory, some as high as 145%, and slightly higher freight. Selling, general and administrative costs rose to $1.8 million, largely from $250,000 of patent-related legal expenses that fully offset a $250,000 licensing gain, resulting in a net loss of $565,407, or $0.06 per share.

The company ended the quarter with $2.5 million in cash, $13.0 million in short-term U.S. Treasury investments, $4.0 million in long-term Treasuries and an undrawn $5.0 million credit facility, supporting liquidity despite ongoing macroeconomic, tariff and supply chain uncertainties.

Form 10-Q
Rhea-AI Summary

Koss Corporation reported a return to profitability for the quarter ended September 30, 2025. Net sales were $4,070,778, up 27.1% year over year, driven by a large education order, a 22.5% increase in direct‑to‑consumer sales, and stronger Asia demand, partly offset by delayed European re‑orders. Gross margin improved to 40.0% from 36.6%.

Operating discipline helped: selling, general and administrative expenses fell 7.5% to $1,674,732. Interest income of $293,128 also supported results. Net income was $243,729 versus a loss of $419,535 a year ago, with diluted EPS of $0.03. U.S. sales rose to $3,321,738, while export sales were $749,040.

Liquidity remained solid with cash and cash equivalents of $2,515,913, short‑term investments of $13,942,994, and no borrowings under a $5,000,000 credit facility. Operating cash flow was $762,617, aided by a $512,000 IRS payroll tax refund. The company settled a patent matter for $22,200. Management noted tariff volatility and a federal government shutdown have created timing risks for certain orders.